NCT00168441View on ClinicalTrials.gov

A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia

PHASE2CompletedINTERVENTIONAL

Enrollment

117

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Postherpetic Neuralgia

Interventions

DRUG

Botulinum Toxin Type A

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allergan

INDUSTRY